title: Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study.
abstract: With an increasing use of traditional Chinese medicine (TCM) in type 2 diabetes mellitus (T2DM), evidence of long-term benefit with adjunctive TCM treatment is limited. This study investigated whether the concurrent TCM treatment reduces the risk of vascular complications in T2DM patients by using a large population from National Health Insurance Research Database (NHIRD).We identified 33,457 adult patients with newly diagnosed T2DM using anti-diabetic agents from a random sample of one million beneficiaries in the NHIRD between January 1, 2000 and December 31, 2011. We recruited 1049 TCM users (received TCM over 30 days with a diagnosis of T2DM) and randomly selected 4092 controls as the non-TCM cohort at a ratio of 1:4 frequency-matched by age, sex, hypertension, hyperlipidemia, and index year. We investigated the prescription pattern of TCM and conducted a Cox proportional hazards regression to calculate the hazard ratios (HRs) of stroke, chronic kidney diseases (CKD), and diabetic foot between the 2 cohorts.In the TCM cohort, the prescription pattern of TCM was different between insulin and noninsulin patients. The most common herbs were Dan-Shen (Radix Salviae Miltiorrhizae) in noninsulin group and Da-Huang (Radix et Rhizoma Rhei) in insulin group. The most common formulae were Liu-Wei-Di-Huang-Wan in noninsulin group and Yu-Quan-Wan in insulin group. Although no significant reduction in the hazard ratio of CKD and diabetic foot, the incidence rate of stroke was 7.19 per 1000 person-years in the TCM cohort and 10.66 per 1000 person-years in the control cohort, respectively. After adjustment of age, sex, hypertension, hyperlipidemia, and antidiabetes agent use (including sulfonylureas, α-glucosidase, metformin, meglitinide, thiazolidinediones, and insulin), TCM cohorts were found to have a 33% decreased risk of stroke (95% CI = 0.46-0.97; P < 0.05).This population-based retrospective study showed that the complementary TCM therapy might associate with the decreased risk of stroke in T2DM, suggesting TCM as an adjunctive therapy for T2DM to prevent subsequent stroke.
authors.affiliation: From the Department of Chinese Medicine, China Medical University Hospital, Taichung (A-LL, M-FS, H-RY); Department of Chinese Medicine, Buddhist Dalin Tzu Chi General Hospital, Chiayi (B-CC); Management Office for Health Data (C-HM); Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung (H-RY); Research Center for Chinese Medicine and Acupuncture (M-FS, H-RY); and School of Chinese Medicine, China Medical University, Taichung, Taiwan (M-FS, H-RY).
authors.forename: Ai-Lin
authors.initials: AL
authors.lastname: Lee
authors.forename: Bor-Chyuan
authors.initials: BC
authors.lastname: Chen
authors.forename: Chih-Hsin
authors.initials: CH
authors.lastname: Mou
authors.forename: Mao-Feng
authors.initials: MF
authors.lastname: Sun
authors.forename: Hung-Rong
authors.initials: HR
authors.lastname: Yen
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008516:Medicine, Chinese Traditional / Q000379:methods; D008875:Middle Aged; D012042:Registries; D012189:Retrospective Studies; D013624:Taiwan / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents
references.citation: J Ethnopharmacol. 2007 Aug 15;113(1):91-9
references.pmid: 17606344
references.citation: Chem Biol Drug Des. 2014 Nov;84(5):513-21
references.pmid: 24725674
references.citation: Biol Pharm Bull. 2008 Mar;31(3):431-5
references.pmid: 18310905
references.citation: J Ethnopharmacol. 2015 Dec 24;176:311-20
references.pmid: 26549268
references.citation: Int J Mol Sci. 2012 Nov 08;13(11):14565-78
references.pmid: 23203081
references.citation: Chem Pharm Bull (Tokyo). 2004 Nov;52(11):1295-301
references.pmid: 15516749
references.citation: Biol Pharm Bull. 2007 May;30(5):1015-20
references.pmid: 17473455
references.citation: J Ethnopharmacol. 2013 Aug 26;149(1):321-7
references.pmid: 23827759
references.citation: Diabetes Res Clin Pract. 2003 Jul;61 Suppl 1:S9-S18
references.pmid: 12880690
references.citation: Am J Chin Med. 2013;41(4):849-64
references.pmid: 23895156
references.citation: Nat Rev Immunol. 2011 Feb;11(2):98-107
references.pmid: 21233852
references.citation: Ann N Y Acad Sci. 2009 Aug;1172:172-80
references.pmid: 19743552
references.citation: Phytother Res. 1999 Sep;13(6):484-8
references.pmid: 10479758
references.citation: Exp Diabetes Res. 2011;2011:947138
references.pmid: 21754922
references.citation: J Ethnopharmacol. 2004 Jan;90(1):39-43
references.pmid: 14698506
references.citation: J Ethnopharmacol. 2008 Jan 17;115(2):184-93
references.pmid: 17996413
references.citation: Evid Based Complement Alternat Med. 2013;2013:193084
references.pmid: 23762108
references.citation: J Pharm Pharmacol. 2004 Oct;56(10):1299-305
references.pmid: 15482645
references.citation: Diabetes Care. 2004 May;27(5):1047-53
references.pmid: 15111519
references.citation: Drug Discov Ther. 2010 Apr;4(2):129-34
references.pmid: 22491170
references.citation: Br J Pharmacol. 2010 Sep;161(1):113-26
references.pmid: 20718744
references.citation: J Ethnopharmacol. 2008 Jun 19;118(1):46-50
references.pmid: 18440169
references.citation: J Auton Nerv Syst. 1997 Mar 19;63(1-2):46-50
references.pmid: 9089538
references.citation: J Agric Food Chem. 2010 Jul 14;58(13):7685-92
references.pmid: 20527984
references.citation: Evid Based Complement Alternat Med. 2013;2013:201329
references.pmid: 23843864
references.citation: Yakugaku Zasshi. 2007 Sep;127(9):1509-13
references.pmid: 17827932
references.citation: J Ethnopharmacol. 2013 Dec 12;150(3):851-9
references.pmid: 24120517
references.citation: J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):275-80
references.pmid: 19429433
references.citation: J Pharm Pharmacol. 2006 Apr;58(4):535-45
references.pmid: 16597372
references.citation: Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):87-92
references.pmid: 19067674
references.citation: Fitoterapia. 2010 Apr;81(3):173-7
references.pmid: 19699280
references.citation: J Clin Invest. 2015 May;125(5):1968-78
references.pmid: 25844899
references.citation: J Ethnopharmacol. 2015 Dec 24;176:9-16
references.pmid: 26481605
references.citation: Am J Med. 2010 Mar;123(3 Suppl):S3-11
references.pmid: 20206730
references.citation: Physiol Meas. 2010 May;31(5):633-47
references.pmid: 20308770
references.citation: BMC Complement Altern Med. 2012 Aug 24;12:137
references.pmid: 22920190
references.citation: Int J Pediatr Otorhinolaryngol. 2015 Apr;79(4):591-7
references.pmid: 25704847
references.citation: J Diabetes. 2011 Sep;3(3):184-200
references.pmid: 21631896
references.citation: Evid Based Complement Alternat Med. 2013;2013:969824
references.pmid: 23983807
references.citation: Phytomedicine. 2008 May;15(5):313-20
references.pmid: 17949960
references.citation: Chin Med. 2009 Jun 12;4:11
references.pmid: 19523223
references.citation: J Pharm Pharmacol. 2005 Sep;57(9):1205-12
references.pmid: 16105242
references.citation: Neurosci Lett. 2011 Apr 25;494(2):114-8
references.pmid: 21376780
references.citation: Diabetes Obes Metab. 2011 Apr;13(4):289-301
references.pmid: 21205111
references.citation: Metabolism. 2009 Oct;58(10):1372-8
references.pmid: 19501858
references.citation: Nephron Exp Nephrol. 2004;97(2):e38-48
references.pmid: 15218322
references.citation: Mol Cell Neurosci. 2013 Mar;53:14-25
references.pmid: 23026562